Bismuth Subsalicylate: Pharmacopoeial Reference, Mechanism, and Research Notes

Bismuth subsalicylate (INN: bismuth subsalicylate, USAN: bismuth subsalicylate) is a basic bismuth salt of salicylic acid, listed in the United States Pharmacopeia and the European Pharmacopoeia as a pharmaceutical substance with antacid and antidiarrheal designations. Its molecular formula is C₇H₅BiO₄, molecular weight approximately 362.09 g/mol, and its CAS registry number is 14882-18-9. These three identifiers are what allow it to be cross-checked against a Certificate of Analysis: a lot whose label lists any of them inconsistently is a lot to inspect, not a lot to use.

The official monographs specify the assay range (typically 56.0-58.0% bismuth by complexometric titration on dried basis), limits for free salicylate, lead, and arsenic, and the appearance (fine white to off-white crystalline powder, odorless or faint salicylate note). For research-vial workflows these limits are the cleanest pass/fail filter the field has: a lot whose COA reproduces them can be used as a reference standard, and a lot whose COA does not is by definition non-compendial material.

The mechanism is not the bismuth cation alone and not the salicylate alone but the combined salt. In acidic aqueous media the compound hydrolyzes into bismuth oxychloride and salicylic acid; the bismuth half delivers the mucosal-coating and weak antimicrobial activity, while the salicylate half delivers the prostaglandin-inhibitor and antisecretory effect. Treating the two halves as additive — "bismuth dose + aspirin dose" — is a common error in informal write-ups; the actual bioavailability of each half is set by the hydrolysis kinetics at gastric pH, which the monographs describe but do not summarize.

Quantitatively, the salicylate released from a 525 mg chewable dose (a common over-the-counter oral dose) yields roughly 263 mg of free salicylate, sufficient for an analgesic-grade systemic exposure if multiple doses are taken. This is the same salicylate released by acetylsalicylic acid; the difference is the co-administered bismuth cation, which slows gastrointestinal transit and which is why the substance appears on drug-interaction lists even though it is sold over the counter. We discuss the corresponding stool-coloring property as a separate observation because the chemistry travels with the salt, not with the active symptom.

Two research-vial reasons explain the recurring presence of bismuth subsalicylate in peptide-science search patterns. First, it is one of the few compendial substances whose pharmacopoeial monograph mentions a peptide-adjacent packaging term (the USP lists specific silicone-elastomer closures compatible with bismuth-salicylate suspension); second, it is a default reference impurity in a few well-known reversed-phase peptide assays, where it serves as a UV-active marker for column conditioning. Neither role implies any biological link between bismuth and a peptide — the connection is purely instrumental.

The peptide science pillar covers the analytical instruments used to make these references meaningful; a useful companion read is PT-141 reconstitution, which uses an entirely different class of reagent (sterile water for injection, bacteriostatic water) and contrasts the strict-compendial style of bismuth subsalicylate with the simpler peptide-grade standard. Same arithmetic, different ends: identify the substance, check the certificate, choose the carrier that the certificate was issued against.

Is bismuth subsalicylate the same as bismuth subcitrate? No. They are different anions (salicylate vs. citrate); the citrate salt is the triple-therapy component of Helicobacter pylori eradication, the salicylate salt is not.

What document confirms a lot is compendial-grade? The USP or Ph. Eur. monograph plus a lot-specific COA that reproduces the listed tests (assay, heavy metals, loss on drying, free salicylate). Without those two, a sample labeled "USP grade" is just a label.

Step 1 — extract the parameters. Start with the claims made about Bismuth Subsalicylate and write down every number you can find: purity, net content, fill mass, salt form, and the analytical method named. Numbers that do not appear are as important as numbers that do; the gap list is your first finding. Step 2 — normalize before comparing. Convert every figure to the same basis: per milligram of net peptide content, at the stated lot purity, in the stated salt form. The comparison table above shows which parameters move the answer most; net content alone typically shifts effective figures by 15–30%. Step 3 — grade the source. A batch-linked COA outranks a representative chromatogram, which outranks a marketing claim with no artifact behind it. When two sources conflict, trust the more specific, more recent, more checkable one — and note the conflict rather than averaging it away. The full evidence hierarchy is defined in the peptide science pillar; a worked example on a neighboring topic is on What Are Pepitas? Pumpkin Seed Anatomy, Protein Profile, and Research Signals.

The parameters below are the ones every peptide buyer or laboratory should be able to read off a certificate of analysis. Compare what each parameter measures, what honest values look like, and what a red flag looks like, before using any vendor's figures.

Table: Parameter comparison: how the quality numbers differ — apply it to any page in this cluster.